Exopharm requests trading halt ahead of capital raising for recently approved 20-patient phase 1 trial
23 July 2019 As reported in Biotech Daily Exopharm says it is ready for a 20-patient phase I trial of its Plexaris exosomo treatment for would healing, and has requesting a trading halt for a capital raising. Exopharm…
Read MoreSmileyscope & Two Bulls Acknowledged for World-Class Digital Excellence in Winning the acclaimed Webby Award
23 July 2019 We were honoured and thrilled to have won the Webby Award with our amazing digital team Two Bulls. Webby Award, presented by The International Academy of Digital Arts and Sciences is described as “The Internet’s…
Read MoreSmileyscope: Fundraising to Meet International Demand
23 July 2019 June and July have been very productive months for Smileyscope, as interest in our product continues to grow in both Australia and the USA. Following our highly successful clinical trial publication in The Journal of…
Read MoreUpdate on Distributor Appointments – LBT Innovations
22 July 2019 Adelaide, Australia: LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to provide this update on recent activities related to the appointment of distributors…
Read MorePlanet Innovation Wins Top Medical Design Award and Digital App Award
18 July 2019 Planet Innovation took home the Good Design Awards’ top gong for medical design for our work on Clever Culture Systems’ APAS Independence instrument, along with a digital design award for Uniting NSW’s Mosaic app. Clever…
Read MoreDementia Research gets $21 million Boost in Funding by Federal Government
18 July 2019 More than a dozen research projects to better understand dementia will be given a total of $21 million in federal government funding. The 13 projects focus on risk reduction, prevention and tracking of dementia, the…
Read MoreImagion up 155% on Magsense FDA Breakthrough Designation
18 July 2019 As reported in Biotech Daily Imagion says the US Food and Drug Administration has granted ‘breakthrough device designation’ for its Magsense HER2 breast cancer staging test. Imagion said devices that provided a more effective treatment…
Read MoreBuilding an In-Vitro Diagnostic Portfolio – Sienna Cancer Diagnostics Ltd
18 July 2019 As reported in Biotech Daily Sienna Chief Executive Officer Matthew Hoskin says the company is building a portfolio of in-vitro cancer diagnostic products to support researchers and laboratories. Mr Hoskin told Biotech Daily that with…
Read MoreAusBiotech and Johnson & Johnson Innovation 2019 Industry Excellence Awards
18 July 2019 (Nominations close – 27 September) Each year, the AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards are presented at the AusBiotech national conference to recognise the highest achievers in the Australian life sciences. From…
Read MoreTrajan Strengthens their Health Business with Appointment of Marco Baccanti
18 July 2019 Adelaide, South Australia, Australia Trajan Scientific and Medical (Trajan) has appointed Marco Baccanti as CEO of its joint venture (JV) in nutritional testing, Trajan Nutrition. Mr. Baccanti’s appointment strengthens Trajan Nutrition to accelerate the growth…
Read MoreD+I win 2019 Product of the Year
17 July 2019 At last week’s Good Design Awards Ceremony, D+I was awarded the honour of 2019 Product of the Year for the Inventia Rastrum 3D Bioprinter. We am excited to share with you the D+I showreel, featuring…
Read MoreServier Australia & BioCurate Strike an Agreement to Collaborate and Accelerate Discoveries of New Therapeutics and Drugs
16 July 2019 Paris & Melbourne, – Servier Australia, the subsidiary of Servier Group, an international pharmaceutical company, and BioCurate, a joint venture company of Monash University and The University of Melbourne with support from the Victorian State…
Read More
